Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021
The global vascular stents market is projected to reach USD 17.68 billion by 2021 from USD 12.21 billion in 2016, at a CAGR of 7.7% from 2016 to 2021.
Major factors contributing to the growth of the global vascular stents market include technological advancements, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and rising geriatric population. However, the presence of alternative treatments for cardiovascular diseases, stringent regulations for product approvals, and numerous cases of product failure and recalls are the major factors that are expected to restrain the growth of this market during the forecast period of 2016 to 2021.
Various companies are focusing on R&D activities to improve their vascular stent offerings. Companies like Abbott Laboratories and Boston Scientific are focusing on the development of biodegradable stents to offer effective products that overcome the complications caused by thrombosis [resulting from long-term device implantation]. For instance, in May 2014, Boston Scientific (U.S.) launched the Promus PREMIER Everolimus-eluting Platinum Chromium Coronary Stent System in Japan.
Currently, the vascular stents market is witnessing a new phase of technology development with the launch of fully dissolving stents. In July 2016, Abbott Laboratories (U.S.) received the U.S. FDA approval to commercially launch its Absorb bioresorbable heart stent. Absorb is the fully dissolving stent approved for the treatment of CAD. Furthermore, a number of bioabsorbable stents for treating PAD are in clinical trials. Some of these products include 480 Biomedical’s Stanza bioresorbable self-expanding scaffold [which is currently under SPIRIT trial and will be used to treat PAD for superficial femoral artery (SFA)] and the Esprit bioresorbable vascular scaffold (BVS) from Abbott Vascular [will be used in the treatment of PAD for SFA and iliac lesions].
The Asian market is estimated to register the highest growth during the forecast period. The high-growth in this regional segment can be attributed to the presence of a large population base, growing prevalence of vascular diseases, rising adoption of advanced technologies, and low manufacturing costs for medical devices in emerging Asian countries.
Research Coverage:
This market is categorized on the basis of product, type, mode of delivery, material, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
Major factors contributing to the growth of the global vascular stents market include technological advancements, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and rising geriatric population. However, the presence of alternative treatments for cardiovascular diseases, stringent regulations for product approvals, and numerous cases of product failure and recalls are the major factors that are expected to restrain the growth of this market during the forecast period of 2016 to 2021.
Various companies are focusing on R&D activities to improve their vascular stent offerings. Companies like Abbott Laboratories and Boston Scientific are focusing on the development of biodegradable stents to offer effective products that overcome the complications caused by thrombosis [resulting from long-term device implantation]. For instance, in May 2014, Boston Scientific (U.S.) launched the Promus PREMIER Everolimus-eluting Platinum Chromium Coronary Stent System in Japan.
Currently, the vascular stents market is witnessing a new phase of technology development with the launch of fully dissolving stents. In July 2016, Abbott Laboratories (U.S.) received the U.S. FDA approval to commercially launch its Absorb bioresorbable heart stent. Absorb is the fully dissolving stent approved for the treatment of CAD. Furthermore, a number of bioabsorbable stents for treating PAD are in clinical trials. Some of these products include 480 Biomedical’s Stanza bioresorbable self-expanding scaffold [which is currently under SPIRIT trial and will be used to treat PAD for superficial femoral artery (SFA)] and the Esprit bioresorbable vascular scaffold (BVS) from Abbott Vascular [will be used in the treatment of PAD for SFA and iliac lesions].
The Asian market is estimated to register the highest growth during the forecast period. The high-growth in this regional segment can be attributed to the presence of a large population base, growing prevalence of vascular diseases, rising adoption of advanced technologies, and low manufacturing costs for medical devices in emerging Asian countries.
Research Coverage:
This market is categorized on the basis of product, type, mode of delivery, material, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of top players in the vascular stents market. The report analyzes this market by product, type, mode of delivery, material, end user, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the vascular stents market
- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the vascular stents market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for vascular stents across regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular stents market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 KEY INDUSTRY INSIGHTS
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VASCULAR STENTS: MARKET OVERVIEW
4.2 VASCULAR STENTS MARKET, BY PRODUCT (2016–2021)
4.3 VASCULAR STENTS MARKET, BY MODE OF DELIVERY (2016 VS. 2021)
4.4 VASCULAR STENTS MARKET, BY MATERIAL (2016 VS. 2021)
4.5 PERIPHERAL VASCULAR STENTS MARKET, BY TYPE (2016)
4.6 VASCULAR STENTS MARKET, BY END USER (2016 VS. 2021)
4.7 GEOGRAPHIC SNAPSHOT: VASCULAR STENTS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Innovations in Stenting Technologies
5.2.1.2 Rising Incidence of Vascular Diseases and Subsequent Growth in the Number of Angioplasty Procedures
5.2.1.3 Increasing Preference for Minimally Invasive Procedures
5.2.1.4 Rapid Growth in the Geriatric Population
5.2.2 RESTRAINTS
5.2.2.1 Availability of Alternative Treatment Methods for Vascular Diseases
5.2.2.2 Product Failures and Recalls
5.2.3 OPPORTUNITIES
5.2.3.1 Development of Bioresorbable Stents
5.2.3.2 Emerging Markets
5.2.4 CHALLENGES
5.2.4.1 Complications Associated with Stent Implantation
5.2.4.2 Declining Costs of Stents
5.3 REGULATORY LANDSCAPE
5.4 PRODUCT PIPELINE
6 VASCULAR STENTS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 DRUG-ELUTING STENTS
6.3 BARE-METAL STENTS
6.4 BIOABSORBABLE STENTS
7 VASCULAR STENTS MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 CORONARY STENTS
7.3 PERIPHERAL STENTS
7.3.1 CAROTID ARTERY STENTS
7.3.2 RENAL ARTERY STENTS
7.3.3 FEMORAL ARTERY STENTS
7.3.4 ILIAC ARTERY STENTS
7.3.5 OTHER PERIPHERAL STENTS
7.4 EVAR STENT GRAFTS
7.4.1 ABDOMINAL AORTIC ANEURYSM STENTS
7.4.2 THORACIC AORTIC ANEURYSM STENTS
8 VASCULAR STENTS MARKET, BY MODE OF DELIVERY
8.1 INTRODUCTION
8.2 BALLOON-EXPANDABLE STENTS
8.3 SELF-EXPANDING STENTS
9 VASCULAR STENTS MARKET, BY MATERIAL
9.1 INTRODUCTION
9.2 METALLIC STENTS
9.2.1 COBALT CHROMIUM
9.2.2 PLATINUM CHROMIUM
9.2.3 NICKEL TITANIUM
9.2.4 STAINLESS STEEL
9.3 OTHER STENTS
10 VASCULAR STENTS MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS AND CARDIAC CENTERS
10.3 AMBULATORY SURGICAL CENTERS
11 VASCULAR STENTS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 U.K.
11.3.4 REST OF EUROPE
11.4 ASIA
11.5 REST OF THE WORLD
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET RANKING ANALYSIS, VASCULAR STENTS MARKET
12.3 VENDOR DIVE OVERVIEW
12.3.1 VANGUARDS
12.3.2 DYNAMIC PLAYERS
12.3.3 INNOVATORS
12.3.4 EMERGING PLAYERS
12.4 BUSINESS STRATEGY (FOR ALL 25 PLAYERS)
12.5 PRODUCT OFFERINGS (FOR ALL 25 PLAYERS)
*Top 25 companies analyzed for this study are - Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), Biosensors International (Singapore), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), Braile Biom?dica (Brazil), C. R. Bard (U.S.), Cook Medical (U.S.), Cordis Corporation (U.S.), Endologix, Inc. (U.S.), GRINM Advanced Materials Co., Ltd (China), InSitu Technologies (U.S.), JOTECH GmBH (Germany), Lifetech Scientific Inc. (China), Lombard Medical (U.K.), Medtronic plc (Ireland), Meril Life Sciences (India), Microport Scientifc Corporation (China), OrbusNeich (Hong Kong), S&G Biotech (South Korea), STENTYS S.A. (France), Terumo Corporation (Japan), Translumina GmBH (Germany), Vascular Concepts (India), and W. L. Gore & Associates (U.S.).
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 INTRODUCTION
13.2 MEDTRONIC PLC
13.3 ABBOTT LABORATORIES
13.4 BOSTON SCIENTIFIC CORPORATION
13.5 BIOTRONIK SE & CO. KG
13.6 B. BRAUN MELSUNGEN AG
13.7 TERUMO CORPORATION
13.8 MICROPORT SCIENTIFIC CORPORATION
13.9 MERIL LIFE SCIENCES PVT. LTD.
13.10 VASCULAR CONCEPTS LIMITED
13.11 C.R. BARD, INC.
13.12 W.L. GORE AND ASSOCIATES, INC.
13.13 ENDOLOGIX, INC.
13.14 LOMBARD MEDICAL
13.15 TRANSLUMINA GMBH
13.16 JOTEC GMBH
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS FROM INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
14.5 AVAILABLE CUSTOMIZATIONS
14.6 RELATED REPORTS
14.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 KEY INDUSTRY INSIGHTS
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VASCULAR STENTS: MARKET OVERVIEW
4.2 VASCULAR STENTS MARKET, BY PRODUCT (2016–2021)
4.3 VASCULAR STENTS MARKET, BY MODE OF DELIVERY (2016 VS. 2021)
4.4 VASCULAR STENTS MARKET, BY MATERIAL (2016 VS. 2021)
4.5 PERIPHERAL VASCULAR STENTS MARKET, BY TYPE (2016)
4.6 VASCULAR STENTS MARKET, BY END USER (2016 VS. 2021)
4.7 GEOGRAPHIC SNAPSHOT: VASCULAR STENTS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Innovations in Stenting Technologies
5.2.1.2 Rising Incidence of Vascular Diseases and Subsequent Growth in the Number of Angioplasty Procedures
5.2.1.3 Increasing Preference for Minimally Invasive Procedures
5.2.1.4 Rapid Growth in the Geriatric Population
5.2.2 RESTRAINTS
5.2.2.1 Availability of Alternative Treatment Methods for Vascular Diseases
5.2.2.2 Product Failures and Recalls
5.2.3 OPPORTUNITIES
5.2.3.1 Development of Bioresorbable Stents
5.2.3.2 Emerging Markets
5.2.4 CHALLENGES
5.2.4.1 Complications Associated with Stent Implantation
5.2.4.2 Declining Costs of Stents
5.3 REGULATORY LANDSCAPE
5.4 PRODUCT PIPELINE
6 VASCULAR STENTS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 DRUG-ELUTING STENTS
6.3 BARE-METAL STENTS
6.4 BIOABSORBABLE STENTS
7 VASCULAR STENTS MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 CORONARY STENTS
7.3 PERIPHERAL STENTS
7.3.1 CAROTID ARTERY STENTS
7.3.2 RENAL ARTERY STENTS
7.3.3 FEMORAL ARTERY STENTS
7.3.4 ILIAC ARTERY STENTS
7.3.5 OTHER PERIPHERAL STENTS
7.4 EVAR STENT GRAFTS
7.4.1 ABDOMINAL AORTIC ANEURYSM STENTS
7.4.2 THORACIC AORTIC ANEURYSM STENTS
8 VASCULAR STENTS MARKET, BY MODE OF DELIVERY
8.1 INTRODUCTION
8.2 BALLOON-EXPANDABLE STENTS
8.3 SELF-EXPANDING STENTS
9 VASCULAR STENTS MARKET, BY MATERIAL
9.1 INTRODUCTION
9.2 METALLIC STENTS
9.2.1 COBALT CHROMIUM
9.2.2 PLATINUM CHROMIUM
9.2.3 NICKEL TITANIUM
9.2.4 STAINLESS STEEL
9.3 OTHER STENTS
10 VASCULAR STENTS MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS AND CARDIAC CENTERS
10.3 AMBULATORY SURGICAL CENTERS
11 VASCULAR STENTS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 U.K.
11.3.4 REST OF EUROPE
11.4 ASIA
11.5 REST OF THE WORLD
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET RANKING ANALYSIS, VASCULAR STENTS MARKET
12.3 VENDOR DIVE OVERVIEW
12.3.1 VANGUARDS
12.3.2 DYNAMIC PLAYERS
12.3.3 INNOVATORS
12.3.4 EMERGING PLAYERS
12.4 BUSINESS STRATEGY (FOR ALL 25 PLAYERS)
12.5 PRODUCT OFFERINGS (FOR ALL 25 PLAYERS)
*Top 25 companies analyzed for this study are - Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), Biosensors International (Singapore), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), Braile Biom?dica (Brazil), C. R. Bard (U.S.), Cook Medical (U.S.), Cordis Corporation (U.S.), Endologix, Inc. (U.S.), GRINM Advanced Materials Co., Ltd (China), InSitu Technologies (U.S.), JOTECH GmBH (Germany), Lifetech Scientific Inc. (China), Lombard Medical (U.K.), Medtronic plc (Ireland), Meril Life Sciences (India), Microport Scientifc Corporation (China), OrbusNeich (Hong Kong), S&G Biotech (South Korea), STENTYS S.A. (France), Terumo Corporation (Japan), Translumina GmBH (Germany), Vascular Concepts (India), and W. L. Gore & Associates (U.S.).
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 INTRODUCTION
13.2 MEDTRONIC PLC
13.3 ABBOTT LABORATORIES
13.4 BOSTON SCIENTIFIC CORPORATION
13.5 BIOTRONIK SE & CO. KG
13.6 B. BRAUN MELSUNGEN AG
13.7 TERUMO CORPORATION
13.8 MICROPORT SCIENTIFIC CORPORATION
13.9 MERIL LIFE SCIENCES PVT. LTD.
13.10 VASCULAR CONCEPTS LIMITED
13.11 C.R. BARD, INC.
13.12 W.L. GORE AND ASSOCIATES, INC.
13.13 ENDOLOGIX, INC.
13.14 LOMBARD MEDICAL
13.15 TRANSLUMINA GMBH
13.16 JOTEC GMBH
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS FROM INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
14.5 AVAILABLE CUSTOMIZATIONS
14.6 RELATED REPORTS
14.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 PROJECTED INCREASE IN THE GLOBAL POPULATION BETWEEN 2005 AND 2030, BY AGE
Table 2 OTHER IMPORTANT MEDICAL DEVICE REGULATIONS
Table 3 VASCULAR STENTS MARKET: PIPELINE PRODUCTS
Table 4 VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 5 COMMERCIALLY AVAILABLE DRUG-ELUTING STENTS
Table 6 DRUG-ELUTING STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 7 NORTH AMERICA: DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 8 EUROPE: DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 9 COMMERCIALLY AVAILABLE BARE-METAL STENTS
Table 10 BARE-METAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 11 NORTH AMERICA: BARE-METAL STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 12 EUROPE: BARE-METAL STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 13 BIOABSORBABLE STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 14 NORTH AMERICA: BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 15 EUROPE: BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 16 VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table 17 CORONARY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 18 CORONARY STENTS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
Table 19 NORTH AMERICA: CORONARY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 20 EUROPE: CORONARY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 21 GLOBAL PREVALENCE OF PAD, 2010
Table 22 PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 23 PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
Table 24 NORTH AMERICA: PERIPHERAL STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 25 EUROPE: PERIPHERAL STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 26 PERIPHERAL STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 27 CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 28 RENAL ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 29 FEMORAL ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 30 ILIAC ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 31 OTHER PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 32 EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 33 EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2014-2021 (NO. OF PROCEDURES)
Table 34 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 35 EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 36 EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 37 AAA STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 38 GLOBAL TAA STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 39 VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 40 COMMERCIALLY AVAILABLE BALLOON-EXPANDABLE VASCULAR STENTS
Table 41 BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 42 NORTH AMERICA: BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 43 EUROPE: BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 44 COMMERCIALLY AVAILABLE SELF-EXPANDING STENTS
Table 45 SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 46 NORTH AMERICA: SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 47 EUROPE: SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 48 VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 49 METALLIC VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 50 NORTH AMERICA: METALLIC VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 51 EUROPE: METALLIC VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 52 METALLIC VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 53 COMMERCIALLY AVAILABLE COBALT CHROMIUM VASCULAR STENTS
Table 54 COBALT CHROMIUM VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 55 COMMERCIALLY AVAILABLE PLATINUM CHROMIUM VASCULAR STENTS
Table 56 PLATINUM CHROMIUM VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 57 COMMERCIALLY AVAILABLE NICKEL TITANIUM VASCULAR STENTS
Table 58 NICKEL TITANIUM VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 59 COMMERCIALLY AVAILABLE STAINLESS STEEL VASCULAR STENTS
Table 60 STAINLESS STEEL VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 61 OTHER COMMERCIALLY AVAILABLE VASCULAR STENTS
Table 62 OTHER VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 63 NORTH AMERICA: OTHER VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 64 EUROPE: OTHER VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 65 VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 66 VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY REGION, 2014-2021 (USD MILLION)
Table 67 NORTH AMERICA: VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
Table 68 EUROPE: VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
Table 69 VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2014-2021 (USD MILLION)
Table 70 NORTH AMERICA: VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
Table 71 EUROPE: VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
Table 72 VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 73 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 74 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 75 NORTH AMERICA: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 76 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 78 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 79 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 80 NORTH AMERICA: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 81 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 82 U.S.: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 83 U.S.: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 84 U.S.: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 85 U.S.: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 86 U.S.: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 87 CANADA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 88 CANADA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 89 CANADA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 90 CANADA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 91 CANADA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 92 EUROPE: VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 93 EUROPE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 94 EUROPE: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 95 EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 96 EUROPE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 97 EUROPE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 98 EUROPE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 99 EUROPE: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 100 EUROPE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 101 GERMANY: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 102 GERMANY: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 103 GERMANY: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 104 GERMANY: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 105 GERMANY: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 106 FRANCE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 107 FRANCE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 108 FRANCE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 109 FRANCE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 110 FRANCE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 111 U.K.: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 112 U.K.: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 113 U.K.: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 114 U.K.: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 115 U.K.: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 116 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2007 VS. 2014 (% OF GDP)
Table 117 ROE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 118 ROE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 119 ROE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 120 ROE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 121 ROE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 122 ASIA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 123 ASIA: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 124 ASIA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 125 ASIA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 126 ASIA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 127 ASIA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 128 ASIA: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 129 ASIA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 130 ROW: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 131 ROW: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 132 ROW: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 133 ROW: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 134 ROW: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 135 ROW: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 136 ROW: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 137 ROW: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 138 TOP 3 PLAYERS IN THE VASCULAR STENTS MARKET, 2016
Table 1 PROJECTED INCREASE IN THE GLOBAL POPULATION BETWEEN 2005 AND 2030, BY AGE
Table 2 OTHER IMPORTANT MEDICAL DEVICE REGULATIONS
Table 3 VASCULAR STENTS MARKET: PIPELINE PRODUCTS
Table 4 VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 5 COMMERCIALLY AVAILABLE DRUG-ELUTING STENTS
Table 6 DRUG-ELUTING STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 7 NORTH AMERICA: DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 8 EUROPE: DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 9 COMMERCIALLY AVAILABLE BARE-METAL STENTS
Table 10 BARE-METAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 11 NORTH AMERICA: BARE-METAL STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 12 EUROPE: BARE-METAL STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 13 BIOABSORBABLE STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 14 NORTH AMERICA: BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 15 EUROPE: BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
Table 16 VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table 17 CORONARY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 18 CORONARY STENTS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
Table 19 NORTH AMERICA: CORONARY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 20 EUROPE: CORONARY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 21 GLOBAL PREVALENCE OF PAD, 2010
Table 22 PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 23 PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
Table 24 NORTH AMERICA: PERIPHERAL STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 25 EUROPE: PERIPHERAL STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 26 PERIPHERAL STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 27 CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 28 RENAL ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 29 FEMORAL ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 30 ILIAC ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 31 OTHER PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 32 EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 33 EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2014-2021 (NO. OF PROCEDURES)
Table 34 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 35 EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 36 EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 37 AAA STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 38 GLOBAL TAA STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 39 VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 40 COMMERCIALLY AVAILABLE BALLOON-EXPANDABLE VASCULAR STENTS
Table 41 BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 42 NORTH AMERICA: BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 43 EUROPE: BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 44 COMMERCIALLY AVAILABLE SELF-EXPANDING STENTS
Table 45 SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 46 NORTH AMERICA: SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 47 EUROPE: SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 48 VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 49 METALLIC VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 50 NORTH AMERICA: METALLIC VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 51 EUROPE: METALLIC VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 52 METALLIC VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 53 COMMERCIALLY AVAILABLE COBALT CHROMIUM VASCULAR STENTS
Table 54 COBALT CHROMIUM VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 55 COMMERCIALLY AVAILABLE PLATINUM CHROMIUM VASCULAR STENTS
Table 56 PLATINUM CHROMIUM VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 57 COMMERCIALLY AVAILABLE NICKEL TITANIUM VASCULAR STENTS
Table 58 NICKEL TITANIUM VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 59 COMMERCIALLY AVAILABLE STAINLESS STEEL VASCULAR STENTS
Table 60 STAINLESS STEEL VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 61 OTHER COMMERCIALLY AVAILABLE VASCULAR STENTS
Table 62 OTHER VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 63 NORTH AMERICA: OTHER VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 64 EUROPE: OTHER VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 65 VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 66 VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY REGION, 2014-2021 (USD MILLION)
Table 67 NORTH AMERICA: VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
Table 68 EUROPE: VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
Table 69 VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2014-2021 (USD MILLION)
Table 70 NORTH AMERICA: VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
Table 71 EUROPE: VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
Table 72 VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 73 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 74 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 75 NORTH AMERICA: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 76 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 78 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 79 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 80 NORTH AMERICA: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 81 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 82 U.S.: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 83 U.S.: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 84 U.S.: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 85 U.S.: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 86 U.S.: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 87 CANADA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 88 CANADA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 89 CANADA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 90 CANADA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 91 CANADA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 92 EUROPE: VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 93 EUROPE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 94 EUROPE: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 95 EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 96 EUROPE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 97 EUROPE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 98 EUROPE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 99 EUROPE: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 100 EUROPE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 101 GERMANY: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 102 GERMANY: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 103 GERMANY: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 104 GERMANY: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 105 GERMANY: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 106 FRANCE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 107 FRANCE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 108 FRANCE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 109 FRANCE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 110 FRANCE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 111 U.K.: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 112 U.K.: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 113 U.K.: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 114 U.K.: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 115 U.K.: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 116 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2007 VS. 2014 (% OF GDP)
Table 117 ROE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 118 ROE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 119 ROE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 120 ROE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 121 ROE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 122 ASIA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 123 ASIA: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 124 ASIA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 125 ASIA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 126 ASIA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 127 ASIA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 128 ASIA: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 129 ASIA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 130 ROW: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 131 ROW: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 132 ROW: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 133 ROW: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 134 ROW: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
Table 135 ROW: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION)
Table 136 ROW: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 137 ROW: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 138 TOP 3 PLAYERS IN THE VASCULAR STENTS MARKET, 2016
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 KEY DATA FROM SECONDARY SOURCES
Figure 7 KEY DATA FROM PRIMARY SOURCES
Figure 8 DRUG-ELUTING STENTS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
Figure 9 BALLOON-EXPANDABLE STENTS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 10 CORONARY STENTS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
Figure 11 HOSPITALS AND CARDIAC CENTERS FORM MAJOR END USERS OF VASCULAR STENTS
Figure 12 NORTH AMERICA DOMINATED THE VASCULAR STENTS MARKET IN 2016
Figure 13 RISING BURDEN OF VASCULAR DISEASES AND INNOVATIONS IN STENTING TECHNOLOGIES ARE DRIVING THE MARKET GROWTH FOR VASCULAR STENTS DURING THE FORECAST PERIOD
Figure 14 CORONARY STENTS DOMINATED THE VASCULAR STENTS MARKET IN 2016
Figure 15 BALLOON-EXPANDABLE STENTS FORM THE LARGEST MARKET SEGMENT
Figure 16 METALLIC STENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 17 CAROTID STENTS TO DOMINATE THE PERIPHERAL VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
Figure 18 HOSPITALS AND CARDIAC CENTERS FORMED THE LARGEST END USERS IN 2016
Figure 19 ASIA TO REGISTER THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
Figure 20 VASCULAR STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 21 BIOABSORBABLE STENTS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 22 ASIA TO GROW AT THE HIGHEST CAGR IN THE DRUG-ELUTING STENTS MARKET DURING THE FORECAST PERIOD
Figure 23 EVAR STENT GRAFTS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 24 ASIA TO GROW AT THE HIGHEST CAGR IN THE PERIPHERAL STENTS MARKET DURING THE FORECAST PERIOD
Figure 25 BALLOON-EXPANDABLE STENTS TO DOMINATE MARKET FROM 2016 TO 2021
Figure 26 NORTH AMERICA TO DOMINATE THE BALLOON-EXPANDABLE STENTS MARKET FROM 2016 TO 2021
Figure 27 METALLIC STENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 28 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE IN THE METALLIC STENTS MARKET
Figure 29 HOSPITALS AND CARDIAC CENTERS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
Figure 30 NORTH AMERICA TO DOMINATE THE MARKET FOR HOSPITALS AND CARDIAC CENTERS (2016-2021)
Figure 31 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GLOBAL VASCULAR STENTS MARKET IN 2021
Figure 32 NORTH AMERICA: VASCULAR STENTS MARKET SNAPSHOT
Figure 33 EUROPE: VASCULAR STENTS MARKET SNAPSHOT
Figure 34 ASIA: VASCULAR STENTS MARKET SNAPSHOT
Figure 35 ROW: VASCULAR STENTS MARKET SNAPSHOT
Figure 36 MNM DIVE-VENDOR COMPARISON MATRIX
Figure 37 GEOGRAPHIC REVENUE MIX OF THE TOP PLAYERS IN THE VASCULAR STENTS MARKET
Figure 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
Figure 39 MEDTRONIC PLC: PRODUCT OFFERING SCORECARD
Figure 40 MEDTRONIC PLC: BUSINESS STRATEGY SCORECARD
Figure 41 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
Figure 42 ABBOTT LABORATORIES: PRODUCT OFFERING SCORECARD
Figure 43 ABBOTT LABORATORIES: BUSINESS STRATEGY SCORECARD
Figure 44 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016)
Figure 45 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD
Figure 46 BOSTON SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 47 BIOTRONIK SE & CO. KG: PRODUCT OFFERING SCORECARD
Figure 48 BIOTRONIK SE & CO. KG: BUSINESS STRATEGY SCORECARD
Figure 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2016)
Figure 50 B. BRAUN MELSUNGEN AG: PRODUCT OFFERING SCORECARD
Figure 51 B. BRAUN MELSUNGEN AG: BUSINESS STRATEGY SCORECARD
Figure 52 TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
Figure 53 TERUMO CORPORATION: PRODUCT OFFERING SCORECARD
Figure 54 TERUMO CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 55 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015)
Figure 56 MICROPORT SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD
Figure 57 MICROPORT SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 58 MERIL LIFE SCIENCES PVT. LTD: PRODUCT OFFERING SCORECARD
Figure 59 MERIL LIFE SCIENCES PVT. LTD: BUSINESS STRATEGY SCORECARD
Figure 60 VASCULAR CONCEPTS LIMITED: PRODUCT OFFERING SCORECARD
Figure 61 VASCULAR CONCEPTS LIMITED: BUSINESS STRATEGY SCORECARD
Figure 62 C.R. BARD, INC.: COMPANY SNAPSHOT (2016)
Figure 63 C.R. BARD: PRODUCT OFFERING SCORECARD
Figure 64 C.R. BARD: BUSINESS STRATEGY SCORECARD
Figure 65 W. L. GORE & ASSOCIATES, INC.: PRODUCT OFFERING SCORECARD
Figure 66 W. L. GORE & ASSOCIATES, INC.: BUSINESS STRATEGY SCORECARD
Figure 67 ENDOLOGIX, INC.: COMPANY SNAPSHOT (2016)
Figure 68 ENDOLOGIX, INC.: PRODUCT OFFERING SCORECARD
Figure 69 ENDOLOGIX, INC.: BUSINESS STRATEGY SCORECARD
Figure 70 LOMBARD MEDICAL: COMPANY SNAPSHOT (2015)
Figure 71 LOMBARD MEDICAL: PRODUCT OFFERING SCORECARD
Figure 72 LOMBARD MEDICAL: BUSINESS STRATEGY SCORECARD
Figure 73 TRANSLUMINA GMBH: PRODUCT OFFERING SCORECARD
Figure 74 TRANSLUMINA: BUSINESS STRATEGY SCORECARD
Figure 75 JOTEC GMBH: PRODUCT OFFERING SCORECARD
Figure 76 JOTEC GMBH: BUSINESS STRATEGY SCORECARD
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 KEY DATA FROM SECONDARY SOURCES
Figure 7 KEY DATA FROM PRIMARY SOURCES
Figure 8 DRUG-ELUTING STENTS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
Figure 9 BALLOON-EXPANDABLE STENTS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 10 CORONARY STENTS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
Figure 11 HOSPITALS AND CARDIAC CENTERS FORM MAJOR END USERS OF VASCULAR STENTS
Figure 12 NORTH AMERICA DOMINATED THE VASCULAR STENTS MARKET IN 2016
Figure 13 RISING BURDEN OF VASCULAR DISEASES AND INNOVATIONS IN STENTING TECHNOLOGIES ARE DRIVING THE MARKET GROWTH FOR VASCULAR STENTS DURING THE FORECAST PERIOD
Figure 14 CORONARY STENTS DOMINATED THE VASCULAR STENTS MARKET IN 2016
Figure 15 BALLOON-EXPANDABLE STENTS FORM THE LARGEST MARKET SEGMENT
Figure 16 METALLIC STENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 17 CAROTID STENTS TO DOMINATE THE PERIPHERAL VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
Figure 18 HOSPITALS AND CARDIAC CENTERS FORMED THE LARGEST END USERS IN 2016
Figure 19 ASIA TO REGISTER THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
Figure 20 VASCULAR STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 21 BIOABSORBABLE STENTS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 22 ASIA TO GROW AT THE HIGHEST CAGR IN THE DRUG-ELUTING STENTS MARKET DURING THE FORECAST PERIOD
Figure 23 EVAR STENT GRAFTS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 24 ASIA TO GROW AT THE HIGHEST CAGR IN THE PERIPHERAL STENTS MARKET DURING THE FORECAST PERIOD
Figure 25 BALLOON-EXPANDABLE STENTS TO DOMINATE MARKET FROM 2016 TO 2021
Figure 26 NORTH AMERICA TO DOMINATE THE BALLOON-EXPANDABLE STENTS MARKET FROM 2016 TO 2021
Figure 27 METALLIC STENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 28 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE IN THE METALLIC STENTS MARKET
Figure 29 HOSPITALS AND CARDIAC CENTERS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
Figure 30 NORTH AMERICA TO DOMINATE THE MARKET FOR HOSPITALS AND CARDIAC CENTERS (2016-2021)
Figure 31 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GLOBAL VASCULAR STENTS MARKET IN 2021
Figure 32 NORTH AMERICA: VASCULAR STENTS MARKET SNAPSHOT
Figure 33 EUROPE: VASCULAR STENTS MARKET SNAPSHOT
Figure 34 ASIA: VASCULAR STENTS MARKET SNAPSHOT
Figure 35 ROW: VASCULAR STENTS MARKET SNAPSHOT
Figure 36 MNM DIVE-VENDOR COMPARISON MATRIX
Figure 37 GEOGRAPHIC REVENUE MIX OF THE TOP PLAYERS IN THE VASCULAR STENTS MARKET
Figure 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
Figure 39 MEDTRONIC PLC: PRODUCT OFFERING SCORECARD
Figure 40 MEDTRONIC PLC: BUSINESS STRATEGY SCORECARD
Figure 41 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
Figure 42 ABBOTT LABORATORIES: PRODUCT OFFERING SCORECARD
Figure 43 ABBOTT LABORATORIES: BUSINESS STRATEGY SCORECARD
Figure 44 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016)
Figure 45 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD
Figure 46 BOSTON SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 47 BIOTRONIK SE & CO. KG: PRODUCT OFFERING SCORECARD
Figure 48 BIOTRONIK SE & CO. KG: BUSINESS STRATEGY SCORECARD
Figure 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2016)
Figure 50 B. BRAUN MELSUNGEN AG: PRODUCT OFFERING SCORECARD
Figure 51 B. BRAUN MELSUNGEN AG: BUSINESS STRATEGY SCORECARD
Figure 52 TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
Figure 53 TERUMO CORPORATION: PRODUCT OFFERING SCORECARD
Figure 54 TERUMO CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 55 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015)
Figure 56 MICROPORT SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD
Figure 57 MICROPORT SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 58 MERIL LIFE SCIENCES PVT. LTD: PRODUCT OFFERING SCORECARD
Figure 59 MERIL LIFE SCIENCES PVT. LTD: BUSINESS STRATEGY SCORECARD
Figure 60 VASCULAR CONCEPTS LIMITED: PRODUCT OFFERING SCORECARD
Figure 61 VASCULAR CONCEPTS LIMITED: BUSINESS STRATEGY SCORECARD
Figure 62 C.R. BARD, INC.: COMPANY SNAPSHOT (2016)
Figure 63 C.R. BARD: PRODUCT OFFERING SCORECARD
Figure 64 C.R. BARD: BUSINESS STRATEGY SCORECARD
Figure 65 W. L. GORE & ASSOCIATES, INC.: PRODUCT OFFERING SCORECARD
Figure 66 W. L. GORE & ASSOCIATES, INC.: BUSINESS STRATEGY SCORECARD
Figure 67 ENDOLOGIX, INC.: COMPANY SNAPSHOT (2016)
Figure 68 ENDOLOGIX, INC.: PRODUCT OFFERING SCORECARD
Figure 69 ENDOLOGIX, INC.: BUSINESS STRATEGY SCORECARD
Figure 70 LOMBARD MEDICAL: COMPANY SNAPSHOT (2015)
Figure 71 LOMBARD MEDICAL: PRODUCT OFFERING SCORECARD
Figure 72 LOMBARD MEDICAL: BUSINESS STRATEGY SCORECARD
Figure 73 TRANSLUMINA GMBH: PRODUCT OFFERING SCORECARD
Figure 74 TRANSLUMINA: BUSINESS STRATEGY SCORECARD
Figure 75 JOTEC GMBH: PRODUCT OFFERING SCORECARD
Figure 76 JOTEC GMBH: BUSINESS STRATEGY SCORECARD
